Loading clinical trials...
Loading clinical trials...
Evaluation of the Ongoing Safety and Preliminary Efficacy of the Tetanizing Burst Therapy (TBT) System in Subjects Undergoing ICD Replacement Due to End-of-battery Life
Conditions
Interventions
Tetanizing Burst Therapy
Locations
1
United States
Johns Hopkins Hospital
Baltimore, Maryland, United States
Start Date
January 1, 2018
Primary Completion Date
September 1, 2020
Completion Date
December 1, 2020
Last Updated
September 17, 2019
Lead Sponsor
EP Sciences
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions